ClinicalTrials.govpublic full text
Vinorelbine Metronomic Plus Lapatinib for Overexpressing HER-2 Metastatic Breast Cancer
breast cancer, vinorelbine metronomic-lapatinib, chemotherapy, targeted therapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1007061
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.